ATRX and central nervous system cancer: It has been shown that ATRX pathogenic DNA sequence alteration correlates with glioma younger patient age, tumor histological features, and prognosis (Haase et al., 2018), as its mutations are frequently found in high-risk patients with a poor prognosis (van Gerven et al., 2022).